|
|
|
|
|
11.03.26 - 13:03
|
Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026 (GlobeNewswire EN)
|
|
|
ROCKVILLE, Md. and SUZHOU, China, March 11, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred herein as “Ascentage Pharma,” the “Company,” “we,” “us” or “our”), a global, commercial stage, integrated biopharmaceutical company engaged in discovering, developing and commercializing novel, differentiated therapies to address unmet medical needs in cancer, today reported it will release its full year 2025 unaudited results and provide business updates at 7:00 pm Eastern Daylight Time (EDT) on March 25, 2026 / 7:00 am Hong Kong Time (HKT) on March 26, 2026....
|
|
|
11.03.26 - 11:18
|
Corporate News: Huawei (EQS)
|
|
|
Huawei und China Telecom gewinnen GSMA GLOMO Award für die Verbesserung des Lebens von Kindern und Jugendlichen...
|
|
|
|
|
10.03.26 - 10:12
|
Corporate News: Huawei (EQS)
|
|
|
Huawei and China Telecom Win GSMA GLOMO for Enhancing the Lives of Children and Young People...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
27.02.26 - 06:15
|
Research: M Stanley's H-shr Focus List (Table) (AAStocks)
|
|
|
Stocks | Potential Upside from Target PricesAlibaba (BABA.US) | 17.8%CHALCO (601600.SH) | +20.7%CATL (300750.SZ) | 33.3%DUALITYBIO-B (09606.HK) | 41.8%ESPRESSIF (688018.SH)| 30.7%HKEX (00388.HK) | 22%HKT-SS (06823.HK) | 7.1%NARI (600406.SH) | 0.9%PING AN (02318.HK) | 22.6%INOVANCE TECH (300124.SZ) | 25.7%SINOMA SCI & TECH (0......
|
|
|
26.02.26 - 16:48
|
Bluprynt Announces Oversubscribed $4.25M Seed Round to Scale its Compliance OS for Onchain Finance (Business Wire)
|
|
|
Round led by Valor Capital Group with participation from Cultivation Capital, Robinhood, Coinbase Ventures, Quona Capital, Flourish Ventures, Radical Investments, Kazea, and Selah Ventures; joined by notable strategic and individual investors across finance, banking, and complianceWASHINGTON--(BUSINESS WIRE)--Bluprynt, the compliance operating system for digital assets, today announced the close of its $4.25 million Seed round. The oversubscribed round was led by Valor Capital Group, with participation from Cultivation Capital and other investors including Robinhood, Coinbase Ventures, Quona Capital, Kazea, Flourish Ventures, Radical Investments, and Selah Ventures.
The round also included several leading individual and strategic participants, including Ricardo Marino, Vice Chairman of Itaú Unibanco, and Edward Wible, Co-founder of Nubank. They join notable pre-seed backers Mark Cuban, Jeremy and Jules Kroll, Verizon CEO Dan Schulman, former CFTC Chairman Chris Giancarlo, and former FDIC Chair Jelena McW...
|
|
|
26.02.26 - 13:03
|
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates (Business Wire)
|
|
|
– Total revenues grew 17% y-o-y to $127.6 million for the fourth quarter of 2025 and 15% y-o-y to $460.2 million for the full-year 2025
– Zocilurtatug pelitecan (zoci) on track to become Zai Lab's first global oncology launch, with three registration-enabling studies across 2L+ SCLC, 1L SCLC, and extrapulmonary NECs by the end of 2026
– Advancing a differentiated global pipeline, including ZL-1503 (IL-13/IL-31Rα), ZL-6201 (LRRC15 ADC), ZL-1222 (PD-1/IL-12) and ZL-1311 (MUC17/CD3 TCE)
– Key regional programs continue to advance, with KarXT approved in China and commercial launch preparations underway; pivotal data readouts for povetacicept in IgAN and elegrobart in TED expected in 2026
Conference call and webcast today, February 26, 2026, at 8:00 a.m. ET (9:00 p.m. HKT)SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced financial results for the fourth quarter and full-year 2025, along with recent product highlights and corporate updates.
“20...
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
